Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034923.xml
Adipositas - Ursachen, Folgeerkrankungen, Therapie 2021; 15(03): 158-159
DOI: 10.1055/s-0041-1735690
DOI: 10.1055/s-0041-1735690
Abstracts
Wiesbaden: Adipositas-Kongress 2021
3 Efficacy and Safety of Semaglutide 2.4 mg Once-Weekly in Adults With Overweight or Obesity and Type 2 Diabetes (STEP 2)
Zusammenfassung
Semaglutide 2.4 mg, as adjunct to lifestyle intervention, was efficacious for weight management in adults with overweight or obesity and T2D, providing significantly greater weight loss vs. placebo and semaglutide 1.0 mg at week 68.
Publication History
Article published online:
24 September 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany